Reshma Singh
Impact in
- Biotechnology top 2%
- Cancer Research and Treatments
- Listeria monocytogenes in Food Safety
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune responses and vaccinations
- Immune Response and Inflammation
Papers in
- Immunology 12
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 1
-
- Cancer Research and Treatments 5
- Listeria monocytogenes in Food Safety 1
- Co-authors
- Yvonne Y.W. Paterson (5 shared papers)Peter Cresswell (2 shared papers)Anu Wallecha (5 shared papers)Elizabeth M. Jaffee (1 shared paper)John Rothman (3 shared papers)Rasha Abu Eid (1 shared paper)Mikayel Mkrtichyan (1 shared paper)Samir N. Khleif (1 shared paper)
- Journals
- Blood (2 papers)Cancer Immunology Immunotherapy (2 papers)Cancer Research (2 papers)Science Translational Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesAustriaChina
In The Last Decade
Reshma Singh
21 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 61
- Biotechnology 237
- Immunology 436
- Oncology 438
- Genetics 127
- Endocrinology 18
Countries citing papers authored by Reshma Singh
This map shows the geographic impact of Reshma Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma Singh more than expected).
Fields of papers citing papers by Reshma Singh
This network shows the impact of papers produced by Reshma Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma Singh. The network helps show where Reshma Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Reshma Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 393 | |
| 2 | 2008 | 126 | |
| 3 | 2010 | 113 | |
| 4 | 2005 | 97 | |
| 5 | 2018 | 62 | |
| 6 | 2013 | 60 | |
| 7 | 2012 | 49 | |
| 8 | 2006 | 43 | |
| 9 | 2007 | 43 | |
| 10 | 2006 | 42 | |
| 11 | 2013 | 41 | |
| 12 | 2012 | 35 | |
| 13 | 2011 | 29 | |
| 14 | 2006 | 23 | |
| 15 | 2017 | 13 | |
| 16 | 2016 | 12 | |
| 17 | 2025 | 12 | |
| 18 | 2015 | 2 | |
| 19 | Validation of a humanized anti-EGFR variant III chimeric antigen receptor for a Phase I trial of CART-EGFRvIII in glioblastoma | 2015 | 1 |
| 20 | 2022 | 1 |
About Reshma Singh
Reshma Singh is a scholar working on Immunology, Biotechnology, Oncology, Hematology and Ocean Engineering, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (6 papers), Cancer Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (2 papers), Acute Myeloid Leukemia Research (2 papers), Advanced Neural Network Applications (1 paper), Listeria monocytogenes in Food Safety (1 paper) and Immune cells in cancer (1 paper). The work is most often cited by research in Biotechnology (237 citations), Immunology (436 citations), Oncology (438 citations), Genetics (127 citations) and Endocrinology (18 citations). Reshma Singh has collaborated with scholars based in United States, Austria and China. Frequent co-authors include Yvonne Y.W. Paterson, Peter Cresswell, Anu Wallecha, Elizabeth M. Jaffee, John Rothman, Rasha Abu Eid, Mikayel Mkrtichyan, Samir N. Khleif, Robert G. Petit and Huagang Zhang. Their work appears in journals such as Blood, Cancer Immunology Immunotherapy, Cancer Research, Science Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.